Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Novel treatment approach to enable blood group-incompatible transplantations
Third-party funded project
Project title Novel treatment approach to enable blood group-incompatible transplantations
Principal Investigator(s) Hevey, Rachel
Co-Investigator(s) Ricklin, Daniel
Organisation / Research unit Departement Pharmazeutische Wissenschaften / Molecular Pharmacy (Ricklin)
Department Departement Pharmazeutische Wissenschaften
Project start 01.03.2021
Probable end 28.02.2023
Status Completed
Abstract

Transplant shortages have necessitated blood group-incompatible organ/stem cell transplantation. To ease organ deficit and improve patients' lives, we have designed glycopolymers to selectively remove circulating antibodies, reducing dependence on immunosuppresants and associated infection risk.

Financed by Innovation Promotion Agency CTI
   

MCSS v5.8 PRO. 0.460 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
29/03/2024